Abstract:By its unique advantages over traditional medicine, nanomedicine has offered new strategies for cancer treatment. In particular, the development of drug delivery strategies has focused on nanoscale particles to improve bioavailability. However, many of these nanoparticles are unable to overcome tumor resistance to chemotherapeutic agents. Recently, new opportunities for drug delivery have been provided by oligonucleotides that can self-assemble into three-dimensional nanostructures. In this work, we have designed and developed functional DNA nanostructures to deliver the chemotherapy drug doxorubicin (Dox) to resistant cancer cells. These nanostructures have two components. The first component is a DNA aptamer, which forms a dimeric G-quadruplex nanostructure to target cancer cells by binding with nucleolin. The second component is double-stranded DNA (dsDNA), which is rich in -GC- base pairs that can be applied for Dox delivery. We demonstrated that Dox was able to efficiently intercalate into dsDNA and this intercalation did not affect the aptamer's three-dimensional structure. In addition, the Aptamer-dsDNA (ApS) nanoparticle showed good stability and protected the dsDNA from degradation in bovine serum. More importantly, the ApS&Dox nanoparticle efficiently reversed the resistance of human breast cancer cells to Dox. The mechanism circumventing doxorubicin resistance by ApS&Dox nanoparticles may be predominantly by cell cycle arrest in S phase, effectively increased cell uptake and decreased cell efflux of doxorubicin. Furthermore, the ApS&Dox nanoparticles could effectively inhibit tumor growth, while less cardiotoxicity was observed. Overall, this functional DNA nanostructure provides new insights into the design of nanocarriers to overcome multidrug resistance through targeted drug delivery.

One-Pot Synthesis Of Sustained-Released Doxorubicin Silica Nanoparticles For Aptamer Targeted Delivery To Tumor Cells

One-pot Synthesis of Hollow PDA@DOX Nanoparticles for Ultrasound Imaging and Chemo-Thermal Therapy in Breast Cancer

One-pot Construction of Doxorubicin Conjugated Magnetic Silica Nanoparticles

Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica Nanoparticles

Doxorubicin-tethered Fluorescent Silica Nanoparticles for Ph-Responsive Anticancer Drug Delivery

Pollen-Like Silica Nanoparticles As A Nanocarrier For Tumor Targeted And Ph-Responsive Drug Delivery

Self-assembling doxorubicin-prodrug nanoparticles as siRNA drug delivery system for cancer treatment: in vitro and in vivo.

An Efficient Cell-Targeting Drug Delivery System Based on Aptamer-Modified Mesoporous Silica Nanoparticles

One-Pot Construction of Functional Mesoporous Silica Nanoparticles for the Tumor-Acidity-Activated Synergistic Chemotherapy of Glioblastoma

Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for Ph-Sensitive Anticancer Drug Delivery.

Sequential thermo-induced self-gelation and acid-triggered self-release process of drug-conjugated nanoparticles: A strategy for the sustained and controlled drug delivery to tumors

Phenylboronic Acid-Modified Hollow Silica Nanoparticles for Dual-Responsive Delivery of Doxorubicin for Targeted Tumor Therapy.

Ph and Thermal Dual-Responsive Nanoparticles for Controlled Drug Delivery with High Loading Content

A Ph-Responsive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Breast Cancer Therapy

Synthesis and Characterization of Doxorubicin Loaded Ph-Sensitive Magnetic Core-Shell Nanocomposites for Targeted Drug Delivery Applications

Multifunctional Aptamer-Based Nanoparticles for Targeted Drug Delivery to Circumvent Cancer Resistance

Multifunctional Hybrid Silica Nanoparticles for Controlled Doxorubicin Loading and Release with Thermal and Ph Dual Response

Porous Silica-Based Platform Bearing Au/Ag Nanosheets for Targeted Combination Therapy and Fluorescence Imaging

Stimuli-responsive Nanoparticles for the Codelivery of Chemotherapeutic Agents Doxorubicin and Sipd-L1 to Enhance the Antitumor Effect.

DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.

Fabrication of a pH/Redox-Triggered Mesoporous Silica-Based Nanoparticle with Microfluidics for Anticancer Drugs Doxorubicin and Paclitaxel Codelivery